The impact of bias in MoM values on patient risk and screening performance for Down syndrome

Prenatal Diagnosis

Volumn 27, Issue 9, 2007, Pages 840-845

  Nix, Barry ^a   Wright, Dave ^b   Baker, Amy ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Bias in MoM values; Patient specific risk; Screening performance

Indexed keywords

ALGORITHM; ARTICLE; CALCULATION; CLINICAL PROTOCOL; COMPUTER PROGRAM; DOWN SYNDROME; EPIDEMIOLOGICAL DATA; FALSE POSITIVE RESULT; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SIMULATION; SMOKING; STANDARDIZATION; STATISTICAL ANALYSIS; WEIGHT;

BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; HUMANS; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; ROC CURVE;

EID: 34548708465     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1791     Document Type: Article

References (10)

1. Cuckle H. 1995. Improved parameters for risk estimation in Down's syndrome screening. Prenat Diagn 15: 1057-1065.
2. Cuckle H, Wald N, Thompson S. 1987a. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein. Br J Obstet Gynaecol 94: 387-402.
3. Cuckle HS, Wald NJ, Thompson SG. 1987b. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94: 387-402.
4. Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM. 1996. Combining inhibin A with existing second trimester markers in maternal serum screening for Down's syndrome. Prenat Diagn 16: 1095-1100.
5. Spencer K, Souter V, Tul N, Snijders R, Nicholaides KH. 1999. A screening programme for trisomy 21 at 10-14 weeks using fetal NT, maternal serum free β-hCG and PAPP-A. Ultrasound Obstet Gynecol 13: 231-237.
6. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
7. Wald NJ, Huttly W, Hackshaw AK. 2003a. Antenatal screening for Down's syndrome with the quadruple test: 5 year results from a screening programme. Lancet 361: 835-836.
8. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003b. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10(2): 56-104.
9. Wright DE, Bradbury I. 2005. Repeated measures screening for Down's Syndrome. BJOG 112: 80-83.
10. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. 2004. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 24: 762-766.